September 22, 2017 6:31pm

… While the end of the Q gets closer

The issue is the same – expectation or the lack of

 

Pre-open indications: 1 hit and 4 miss (2 by pennies)

 

Out and about: A new “rocket man and woman” CEO moniker award; Cytori’s (CYTX) Marc Hendricks and Linda Power of Northwest Bio (NWBO) having commissioned their companies suicidal drop

 

Are the truths of “our” universe that hard to accept – not here!

I answer one question, in which company should investors commit and keep their money. In the grip of rotating cycles and disparaging trends, what is the price of sector knowledge – a subscription!  


 

Friday’s results have implications to Monday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

 

Henry’omics:

From the pre-open’s newsletter “…pricing hunkers down. How many investors, traders, ETFs and algorithms really comprehend risk in the sector … its cause and effect?”

  • As a long time contrarian – I don’t trust it, until I feel it or see it - MY outlook is that the RegMed and cell therapy sector’s progression remains pessimistic.

I am also in agreement, that sooner than later the likelihood of a sudden unexpected downturn … must be expected!

 

 

Some of MY working trend lines or indications:

… The greatest volume to the downside:  SGMO, KITE, CUR, VSTM and NWBO

… Upside volume was weighted to:  JUNO, MDXG, CAPR, IMUC and ATHX

… Biggest $ downside:  ONCE, RGNX, SGMO, FCSC and ADRO

… Largest $ upside:  JUNO, BLUE, MDXG, BLFS and FATE

… Flat:  VCEL, STML, RENE.L, XON and AGTC

 

Applied Genetic Technologies (AGTC $3.65) was FLAT, getting stuck in the bottom of the barrel and what is the company doing or saying – NOTHING! On 1/3/17 AGTC was priced at $9.55 while 9/22/16 was $8.89 after a split. AGTC had closed down -$0.05 on Thursday after being <Wednesday> flat at $3.65 after Tuesday’s  -$0.025 following CEO Susan Washer, a recipient of the “rocket women” designation for assisting in the destruction of her companies share pricing and doing NOTHING … to mitigate the issues!

CAPR is UP after Thursday’s -$0.03 following Wednesday’s -$0.22 after Tuesday’s +$0.93 after Monday’s +$0.32 on a press release of October’s data release – wait for the erosion! Icarus flew high and crashed into the sea – just another I told you so as CEO Marban gets MY “rocket women CEO” designation!

Biostage (BSTG) as usual went NOWHERE after Thursday’s 0.00 after Wednesday’s down -0.00 – another  failed company kept alive by issues of salary continuation; thus James McGorry gets a “rocket man” designation as BSTG contemplates legal “suicide” – a bankruptcy … IF a judge does NOT rule in their favor in the on-going and unresolved terminal death suit!

Lighting the stock price on fire was:  QURE, CLLS, STML, ISCO, FCSC, ATHX and RGNX to name a few …

MDXG was up +$0.36 while VCEL was flat at $4.95 as OSIR was down -$0.05 while HSGX was up +$0.05

KITE was DOWN with while JUNO was up +$3.52 after an offering along with BLUE (+$0.90), BLCM (+$0.12) – the “runners” of past weeks

Mid-tiers getting “whacked” were: CLBS, XON, ONVO to name a few … and never forget – VTGN

FATE (+$0.18) was up along with AST (+$0.05) and its mothership, BTX (+$0.01)

VSTM (-$0.09), SGMO (-$0.55), RGNX (-$1.15) along with ONCE (-$1.95) and CLLS (-$0.14)

Even PSTI was down -$0.02 after Thursday’s flat at $1.56 after Wednesday’s $0.03 – never holds, it will decline … MORE!

BLFS was up +$0.30 with volume of 132.6 K shares traded after Thursday’s +$0.07 with low volume (66.2 K shares) after yesterday’s -$0.13 after Tuesday’s -$0.14 after Monday’s +$0.44 to $5.29 – something is up as volume is huge, 947.8 K shares traded <3 month average = 170.07 K shares> - it better happen soon like an offering to raise cash and not live on debt or are they preparing for a take-out after 12/31/16’s price of $1.61 … or as I stated yesterday, is there a strategy here or is an Icarus flight pattern process?

 

Reiterating, “It’s just a merry-go-round of share pricing – get on and when the music changes get off – to get back on when the tune changes!”

 

 

Pre-open indications: 1 hit and 4 miss (2 by pennies)

  • Athersys (ATHX) closed up +$0.08 – miss;
  • Biostage (BSTG) closed up +$0.00, basically flat – hit;
  • Capricor (CAPR) closed up +$0.14 – miss;
  • BioLife Solutions (BLFS) closed up +$0.30 – miss;
  • Spark Therapeutics (ONCE) closed down -$1.95 – miss;

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The first hour was negative with an A/DL of 14/23 and 6 flats;

·         The mid-day was negative  with an A/DL of 14/24 and 5 flats;

·         The close was negative with an A/DL of 18/20 and 5 flats;

 

 

Daily analytics:

U.S. stocks ended with slight moves on Friday, as the market's recent upward momentum remained intact.

·         The Dow fell 10 points, or less than 0.1%, to 22,349.

·         The S&P 500 rose 1.5 point to 2,502.

·         The NASDAQ was up 4 points, or 0.1%, to 6,427.

For the week, the Dow rose 0.4%, the S&P rose 0.1%, and the NASDAQ fell 0.3%.

 

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market; Friday traded at 9.59, down -0.83%

  • Thursday traded at 9.67, down -1.12% after Wednesday traded at 9.78, down -3.93% after Tuesday closed at 10.18, up +0.30% after Monday traded at 10.15, down -0.20% and last Friday traded at 10.21, down -2.30%

 

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Friday was up +0.43%

·         Thursday -0.10%

·         Wednesday +0.33%

·         Tuesday was FLAT (haven’t seen that in quite a while)

·         Monday +0.70%

·         Last Friday +0.45%

 

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Friday was down -0.40%

·         Thursday -0.44%

·         Wednesday +0.85%

·         Tuesday -0.67%

·         Monday +0.11%

·         Last Friday -0.07%

 

 

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %

·         Friday’s decliners ranged from -0.04% <KITE -$0.08> to -9.36% <OPXA -$0.10> in 20 equities;

·         Thursday’s decliners ranged from -0.20% <KITE -$0.20 > to -9.36% <OPXA -$0.10 > in 21 equities;

·         Wednesday’s decliners ranged from -0.18% < MESO -$0.01> to -19.63% < NWBO -$0.043> in 23 equities;

·         Tuesday’s decliners ranged from -0.31% <BLCM -$0.04> to -3.73% <MDXG -$0.51> in 21 equities;

·         Monday’s decliners ranged from -0.36% <BSTG -$0.0012> to -6.13% <ONVO -$0.13> in 11 equities;

·         Last Friday’s decliners ranged from -0.19% <BLUE -$0.25> to -6.19% <ONVO -$0.14> in 19 equities;

Versus

… Look at the percentage’s (%) and spreads …

·         Friday’s gainers ranged from +0.18% <MESO +$0.01> to +8.46% <JUNP +$3.52> in 18 equities;

·         Thursday’s gainers ranged from +0.11% <CLLS +$0.03> to +12.01% <QURE +$1.02> in 16 equities;

·         Wednesday’s gainers ranged from +0.11% <CLLS ++0.03> to +17.83% <CUR +$0.21> in 19 equities;

·         Tuesday’s gainers ranged from +0.26% <CLBS +$0.01> to +70.45% <CAPR +$0.93> in 19 equities;

·         Monday’s gainers ranged from +0.16% <KITE +$0.28> to +32% <CAPR +$0.32> in 28 equities;

·         Last Friday’s gainers ranged from +0.66% <ONCE +$0.54> to +8.52% <BLCM +$0.92> in 23 equities;

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.